OPKO Health, Inc. (LON:0KCS)

OPKO Health Statistics

Total Valuation

OPKO Health has a market cap or net worth of GBP 682.38 million. The enterprise value is 706.84 million.

Market Cap	682.38M
Enterprise Value	706.84M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	759.07M
Shares Outstanding	n/a
Shares Change (YoY)	+8.23%
Shares Change (QoQ)	-1.85%
Owned by Insiders (%)	42.38%
Owned by Institutions (%)	25.50%
Float	339.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.51
PB Ratio	0.72
P/TBV Ratio	12.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.22
EV / Sales	1.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.99

Financial Position

The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.31.

Current Ratio	3.97
Quick Ratio	3.21
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-2.08
Interest Coverage	-2.02

Financial Efficiency

Return on equity (ROE) is -17.14% and return on invested capital (ROIC) is -16.92%.

Return on Equity (ROE)	-17.14%
Return on Assets (ROA)	-6.62%
Return on Invested Capital (ROIC)	-16.92%
Return on Capital Employed (ROCE)	-12.27%
Weighted Average Cost of Capital (WACC)	15.32%
Revenue Per Employee	198,203
Profits Per Employee	-73,706
Employee Count	2,275
Asset Turnover	0.29
Inventory Turnover	7.56

Taxes

Income Tax	-11.67M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.11% in the last 52 weeks. The beta is 1.52, so OPKO Health's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	-33.11%
50-Day Moving Average	1.25
200-Day Moving Average	1.35
Relative Strength Index (RSI)	43.09
Average Volume (20 Days)	11,224

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	10.03

Income Statement

In the last 12 months, OPKO Health had revenue of GBP 450.91 million and -167.68 million in losses. Loss per share was -0.22.

Revenue	450.91M
Gross Profit	60.86M
Operating Income	-162.71M
Pretax Income	-179.35M
Net Income	-167.68M
EBITDA	-94.63M
EBIT	-162.71M
Loss Per Share	-0.22

Balance Sheet

The company has 270.76 million in cash and 294.81 million in debt, with a net cash position of -24.05 million.

Cash & Cash Equivalents	270.76M
Total Debt	294.81M
Net Cash	-24.05M
Net Cash Per Share	n/a
Equity (Book Value)	942.09M
Book Value Per Share	1.24
Working Capital	323.36M

Cash Flow

In the last 12 months, operating cash flow was -132.66 million and capital expenditures -9.12 million, giving a free cash flow of -141.78 million.

Operating Cash Flow	-132.66M
Capital Expenditures	-9.12M
Free Cash Flow	-141.78M
FCF Per Share	n/a

Margins

Gross margin is 13.50%, with operating and profit margins of -36.08% and -37.19%.

Gross Margin	13.50%
Operating Margin	-36.08%
Pretax Margin	-39.78%
Profit Margin	-37.19%
EBITDA Margin	-20.99%
EBIT Margin	-36.08%
FCF Margin	n/a

Dividends & Yields

OPKO Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.23%
Shareholder Yield	-8.23%
Earnings Yield	-24.57%
FCF Yield	-20.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OPKO Health has an Altman Z-Score of -0.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.48
Piotroski F-Score	3